Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search

People

  • Healthcare Professionals
  • Patient Support Professionals
  • Researchers
  • Community Leaders
  1. Home
  2. Providers
  3. People
anita_dsouza
Anita D'Souza, MD, MS
Read more
giampaolo_merlini
Giampaolo Merlini, MD
Read more
giampaolo_merlini
Giampaolo Merlini, MD
Read more
michaela_liedtke
Michaela Liedtke, MD
Read more
ronglih_liao
Ronglih Liao, PhD
Read more
kelsey_barrell
Kelsey Barrell, MD
Read more
jose_nativi_nicolau
Jose Nativi-Nicolau, MD
Read more
vaishali_sanchorawala
Vaishali Sanchorawala, MD
Read more
martha_skinner
Martha Skinner, MD
Read more
robert_vescio
Robert A. Vescio, MD
Read more

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • ›› Next page
  • Last » Last page
Subscribe to

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.
Image
Featured CT
external link, opens in a new tab

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login

© 2025 Somebody To Talk To, Inc.

Join us on